BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 28782609)

  • 1. Prodrugs - Recent approvals and a glimpse of the pipeline.
    Rautio J; Kärkkäinen J; Sloan KB
    Eur J Pharm Sci; 2017 Nov; 109():146-161. PubMed ID: 28782609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prodrugs--from serendipity to rational design.
    Huttunen KM; Raunio H; Rautio J
    Pharmacol Rev; 2011 Sep; 63(3):750-71. PubMed ID: 21737530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prodrug strategies to overcome poor water solubility.
    Stella VJ; Nti-Addae KW
    Adv Drug Deliv Rev; 2007 Jul; 59(7):677-94. PubMed ID: 17628203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is prodrug design an approach to increase water solubility?
    Sanches BMA; Ferreira EI
    Int J Pharm; 2019 Sep; 568():118498. PubMed ID: 31301465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prodrug design to improve pharmacokinetic and drug delivery properties: challenges to the discovery scientists.
    Jana S; Mandlekar S; Marathe P
    Curr Med Chem; 2010; 17(32):3874-908. PubMed ID: 20858214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newly Developed Prodrugs and Prodrugs in Development; an Insight of the Recent Years.
    Najjar A; Najjar A; Karaman R
    Molecules; 2020 Feb; 25(4):. PubMed ID: 32079289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prodrugs: Some thoughts and current issues.
    Stella VJ
    J Pharm Sci; 2010 Dec; 99(12):4755-65. PubMed ID: 20821387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prodrugs: design and clinical applications.
    Rautio J; Kumpulainen H; Heimbach T; Oliyai R; Oh D; Järvinen T; Savolainen J
    Nat Rev Drug Discov; 2008 Mar; 7(3):255-70. PubMed ID: 18219308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expanding role of prodrugs in contemporary drug design and development.
    Rautio J; Meanwell NA; Di L; Hageman MJ
    Nat Rev Drug Discov; 2018 Aug; 17(8):559-587. PubMed ID: 29700501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prodrug research: futile or fertile?
    Testa B
    Biochem Pharmacol; 2004 Dec; 68(11):2097-106. PubMed ID: 15498500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prodrugs in medicinal chemistry and enzyme prodrug therapies.
    Walther R; Rautio J; Zelikin AN
    Adv Drug Deliv Rev; 2017 Sep; 118():65-77. PubMed ID: 28676386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physicochemical property trends of marketed prodrugs.
    Landis MS
    Ther Deliv; 2013 Feb; 4(2):225-37. PubMed ID: 23343161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphate moiety in FDA-approved pharmaceutical salts and prodrugs.
    Fulmali A; Bharate SS
    Drug Dev Res; 2022 Aug; 83(5):1059-1074. PubMed ID: 35656613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prodrugs as empowering tools in drug discovery and development: recent strategic applications of drug delivery solutions to mitigate challenges associated with lead compounds and drug candidates.
    Subbaiah MAM; Rautio J; Meanwell NA
    Chem Soc Rev; 2024 Feb; 53(4):2099-2210. PubMed ID: 38226865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prodrug approaches for enhancing the bioavailability of drugs with low solubility.
    Müller CE
    Chem Biodivers; 2009 Nov; 6(11):2071-83. PubMed ID: 19937841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What should be considered on design of a colon-specific prodrug?
    Jung Y; Kim YM
    Expert Opin Drug Deliv; 2010 Feb; 7(2):245-58. PubMed ID: 20095945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleoside Phosphate and Phosphonate Prodrug Clinical Candidates.
    Thornton PJ; Kadri H; Miccoli A; Mehellou Y
    J Med Chem; 2016 Dec; 59(23):10400-10410. PubMed ID: 27559756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The year's new drugs & biologics - 2008.
    Graul AI; Revel L; Barrionuevo M; Cruces E; Rosa E; Verges C; Lupone B; Diaz N; Castaner R
    Drug News Perspect; 2009; 22(1):7-29. PubMed ID: 19209296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The future of prodrugs - design by quantum mechanics methods.
    Karaman R; Fattash B; Qtait A
    Expert Opin Drug Deliv; 2013 May; 10(5):713-29. PubMed ID: 23540707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amorphous Solid Dispersions or Prodrugs: Complementary Strategies to Increase Drug Absorption.
    Rumondor ACF; Dhareshwar SS; Kesisoglou F
    J Pharm Sci; 2016 Sep; 105(9):2498-2508. PubMed ID: 26886316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.